The correlation between extroversion and day-to-day positive affect is 0.5 — as large as the correlation between the heights of fathers and sons.
Snapshot · Huberman Lab
The correlation between extroversion and day-to-day positive affect is 0.5 — as large as the correlation between the heights of fathers and sons.
Where this was said
At 1:19:40 · chapter starts 1:10:28
Huberman shares his own micro-connection experiences — fist bumps with strangers, a Minor Threat shirt shoutout on the boardwalk — and Epley validates them with a hypothesis his lab has long discussed but never found a way to test: connecting with one stranger may warm your feelings about an entire category of people, or even humanity as a whole. Two vivid stories illustrate this — a woman with red glasses who needed to hear she was 'killing it,' and Gustavo on the train heading to culinary school, so proud of his trade path. The chapter pivots to the extroversion-happiness data: r=0.5 going back to Ed Diener's 1980 foundational research; Will Fleeson's finding that acting extroverted for 30 minutes elevates positive affect regardless of personality; and Sonja Lyubomirsky's 2-week study showing lasting shifts. The porcupine metaphor — people who keep their quills out are not making themselves happier — is introduced here.
The correlation between extroversion and daily happiness is 0.5 — as large as the height correlation between fathers and sons. When introverts are asked to act extroverted for even 30 minutes, their positive affect rises. The data are clear: connecting with others lifts everyone, not just the naturally outgoing.
When introverts were asked to act more extroverted for even half an hour in a lab, they reported significantly more positive emotions — regardless of baseline personality.
Animals first sensed light 540 million years ago, triggering an evolutionary acceleration known as the Cambrian explosion within 10 million years.
It is estimated that half of all cortical activity in the human brain is involved in visual function, underscoring vision's central role in intelligence.
Cognitive neuroscience literature shows that by age 6, humans can recognize tens of thousands of different object categories — far more data than early AI systems were trained on.
Only about 3% of FDA-approved drugs have genuinely unclear mechanisms of action, making an unknown mechanism a meaningful early red flag for any compound.
Even compounds that clear preclinical testing often fail in humans: 30 to 50% of drugs entering phase 1 trials do not advance to phase 2, frequently because human behavior differs from animal models.
More than 80% of published BPC-157 research comes from a single academic group whose researchers have IP and commercial interests connected to the molecule, limiting independent replication.
Roughly 100 peptide drugs are already FDA-approved, about 150 more are in clinical trials, and 600–700 are in preclinical development, underscoring the legitimacy of peptide science broadly.
The scientist who discovered BPC-157 refused to disclose the screening method used to identify the compound and has never fully published the parent protein sequence — what Peter Attia calls 'scientific trust me, bro.'
The brain's visual, auditory, and motor cortices light up nearly identically whether an experience is real or imagined, making visualization a form of actual neural training.
We use essential and analytics cookies to run Vuci. To understand how the site is used: Privacy Policy.
Install Vuci on your phone
Add it to your home screen for a faster, app-like experience.
Install Vuci on your phone
Tap the Share button, then “Add to Home Screen”.
A new version is available
Reload to get the latest Vuci.